Clinical Trial Update: Effect of AIV007 by Periocular Administration in Subjects with Macular Edema Secondary to Neovascular Age-related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for AIV007 delivered periocularly in patients with macular edema due to Neovascular Age-Related Macular Degeneration or Diabetic M…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Neovascular Age-related Macular Degeneration

Drugs mentioned

• AIV007

Snippet

Sponsor: AiViva BioPharma, Inc. | Conditions: Neovascular Age-related Macular Degeneration, Diabetic Macular Edema | Phase 1 | Status: ACTIVE_NOT_RECRUITING